A detailed history of West Family Investments, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, West Family Investments, Inc. holds 14,920 shares of AZN stock, worth $958,759. This represents 0.4% of its overall portfolio holdings.

Number of Shares
14,920
Previous 13,277 12.37%
Holding current value
$958,759
Previous $1.04 Million 12.27%
% of portfolio
0.4%
Previous 0.32%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$76.67 - $87.62 $125,968 - $143,959
1,643 Added 12.37%
14,920 $1.16 Million
Q2 2024

Aug 05, 2024

BUY
$66.81 - $80.83 $7,749 - $9,376
116 Added 0.88%
13,277 $1.04 Million
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $4,882 - $5,565
80 Added 0.61%
13,161 $891,000
Q4 2023

Feb 06, 2024

SELL
$61.89 - $69.28 $4,208 - $4,711
-68 Reduced 0.52%
13,081 $881,000
Q3 2023

Nov 02, 2023

BUY
$64.85 - $71.7 $4,409 - $4,875
68 Added 0.52%
13,149 $890,000
Q2 2023

Aug 15, 2023

BUY
$69.91 - $75.81 $914,492 - $991,670
13,081 New
13,081 $936,000
Q4 2022

Feb 08, 2023

SELL
$54.21 - $70.44 $9,974 - $12,960
-184 Reduced 1.39%
13,091 $887,000
Q3 2022

Nov 04, 2022

SELL
$53.02 - $135.75 $85,044 - $217,743
-1,604 Reduced 10.78%
13,275 $728,000
Q2 2022

Aug 12, 2022

SELL
$59.26 - $71.14 $133,453 - $160,207
-2,252 Reduced 13.15%
14,879 $983,000
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $30,757 - $37,050
552 Added 3.33%
17,131 $1.14 Million
Q4 2021

Feb 07, 2022

SELL
$54.02 - $63.83 $12,424 - $14,680
-230 Reduced 1.37%
16,579 $966,000
Q3 2021

Oct 25, 2021

BUY
$55.56 - $60.79 $137,622 - $150,576
2,477 Added 17.28%
16,809 $1.01 Million
Q2 2021

Aug 12, 2021

BUY
$48.42 - $60.18 $693,955 - $862,499
14,332 New
14,332 $858,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $199B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track West Family Investments, Inc. Portfolio

Follow West Family Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Family Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Family Investments, Inc. with notifications on news.